Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Investment Securities (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Gains from Investment Securities for 15 consecutive years, with $103000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities changed 0.0% to $103000.0 in Q2 2025 year-over-year; TTM through Nov 2025 was -$596297.0, a 25.9% decrease, with the full-year FY2025 number at -$48304.0, down 141.56% from a year prior.
  • Gains from Investment Securities was $103000.0 for Q2 2025 at Cryo Cell International, roughly flat from $103000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q2 2021 to a low of -$1.3 million in Q4 2022.
  • A 5-year average of $115665.1 and a median of $80315.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 5035.4% in 2023; the steepest drop was 711.82% in 2023.
  • Cryo Cell International's Gains from Investment Securities stood at $1.6 million in 2021, then crashed by 180.32% to -$1.3 million in 2022, then rose by 24.79% to -$985824.0 in 2023, then skyrocketed by 133.67% to $331897.0 in 2024, then crashed by 68.97% to $103000.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Gains from Investment Securities are $103000.0 (Q2 2025), $103000.0 (Q1 2025), and $331897.0 (Q4 2024).